SNAI2 and neoplasm: Our data can explain why MYOD that is robustly expressed and diagnostic of FN-RMS tumors, can modulate early tumor myoblast-like proliferation but is unable to initiate late myotube-like gene expression that would result in exit from the cell cycle and terminal differentiation when SNAI2 is expressed.